Coronavirus Update: Moderna Prepares For Crucial Phase II Trial Of Vaccine, Japan Takes Steps

At Risk Age Groups Added To Phase I Studies

Plus: Japan pledges rapid approval for remdesivir, GSK launches fund to look into impact of coronavirus on people with HIV.  

Tokyo
Asakusa, Tokyo, Japan. Japan has a relatively small number of COVID-19 cases and deaths compared to other countries, but a recent surge in cases in Tokyo has led to stricter measures being introduced. At the start of the Golden Week holiday, the government is asking citizens to stay at home for the entire period.

Moderna Inc. is looking to move its coronavirus vaccine candidate mRNA-1273 rapidly into Phase II trials.

The company has become one of the frontrunners in the race to develop a vaccine, despite its mRNA-based platform being...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip